Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06939309

Efficacy of Acupuncture for Shoulder Pain Based on Remote Point Selection According to the Meridians

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This double blind randomized controlled trial investigates the immediate efficacy of acupuncture for shoulder pain using remote point selection based on meridian theory. A total of 90 participants with shoulder pain (Numerical Rating Scale ≥ 4) will be randomly assigned in a 1:1:1 ratio to one of three groups: acupuncture SC, acupuncture CS, and rehabilitation. Meridian selection will be determined based on the patient's most painful shoulder movement and corresponding pain location, followed by standardized distal acupoint application. Outcome measures include changes in pain intensity (NRS) and shoulder range of motion assessed at baseline, post-first acupuncture, post-second acupuncture, and 30 minutes post-treatment. Blinded evaluators will conduct all assessments. The study aims to assess the effectiveness of meridian-based remote acupuncture and explore its relationship with shoulder movement patterns and soft tissue involvement.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcupunctureIn this study, both the acupuncture SC group and the acupuncture CS group will receive two acupuncture treatments in one session. The SC group will first receive acupuncture at the standardized acupoint followed by the controlled acupoint, while the CS group will first receive acupuncture at the controlled acupoint followed by the standardized acupoint.
PROCEDURERehabilitationParticipants will complete a 30-minute rehabilitation session, which includes electrotherapy and thermotherapy applied to the shoulder.

Timeline

Start date
2025-04-18
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2025-04-22
Last updated
2025-04-24

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06939309. Inclusion in this directory is not an endorsement.